Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D MACE

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Journal of Lipid Research|December 7, 2019
Nonsynonymous SNPs in <i>LPA</i> homologous to plasminogen deficiency mutants represent novel null apo(a) allelesBenjamin M Morgan, Aimee N Brown, Nikita Deo, et al.
Science Signaling|March 12, 2020
Structure-based mechanism of preferential complex formation by apoptosis signal-regulating kinasesSarah J Trevelyan, Jodi L Brewster, Abigail E Burgess, et al.
Bioorganic & Medicinal Chemistry Letters|June 8, 2013
Design, synthesis and evaluation of inhibitor of apoptosis protein (IAP) antagonists that are highly selective for the BIR2 domain of XIAPRobert J Ardecky, Kate Welsh, Darren Finlay, et al.
Science Advances|February 26, 2025
DET1 dynamics underlie cooperative ubiquitination by CRL4<sup>DET1-COP1</sup> complexesAbigail E Burgess, Tarren A Loughran, Liam S Turk, et al.
Bioorganic & Medicinal Chemistry Letters|June 18, 2011
Design, synthesis and evaluation of monovalent Smac mimetics that bind to the BIR2 domain of the anti-apoptotic protein XIAPMarcos González-López, Kate Welsh, Darren Finlay, et al.
ACS Chemical Biology|January 18, 2013
Expedient synthesis of highly potent antagonists of inhibitor of apoptosis proteins (IAPs) with unique selectivity for ML-IAPMitchell Vamos, Kate Welsh, Darren Finlay, et al.
Journal of the American College of Cardiology|August 20, 2013
Clinical manifestations of fibromuscular dysplasia vary by patient sex: a report of the United States registry for fibromuscular dysplasiaEsther S H Kim, Jeffrey W Olin, James B Froehlich, et al.
The Journal of Biological Chemistry|October 10, 2009
TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (tnf) to efficiently activate nf-{kappa}b and to prevent tnf-induced apoptosisJames E Vince, Delara Pantaki, Rebecca Feltham, et al.
The Biochemical Journal|November 19, 2024
On the function of TRAP substrate-binding proteins: the isethionate-specific binding protein IsePMichael C Newton-Vesty, Michael J Currie, James S Davies, et al.
Structure (London, England : 1993)|November 6, 2025
Structural basis of isethionate transport by a TRAP transporter from a sulfate-reducing bacteriumMichael C Newton-Vesty, Mariafrancesca Scalise, Sam A Jamieson, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Journal of Lipid Research|December 7, 2019
Nonsynonymous SNPs in <i>LPA</i> homologous to plasminogen deficiency mutants represent novel null apo(a) allelesBenjamin M Morgan, Aimee N Brown, Nikita Deo, et al.
Science Signaling|March 12, 2020
Structure-based mechanism of preferential complex formation by apoptosis signal-regulating kinasesSarah J Trevelyan, Jodi L Brewster, Abigail E Burgess, et al.
Bioorganic & Medicinal Chemistry Letters|June 8, 2013
Design, synthesis and evaluation of inhibitor of apoptosis protein (IAP) antagonists that are highly selective for the BIR2 domain of XIAPRobert J Ardecky, Kate Welsh, Darren Finlay, et al.
Science Advances|February 26, 2025
DET1 dynamics underlie cooperative ubiquitination by CRL4<sup>DET1-COP1</sup> complexesAbigail E Burgess, Tarren A Loughran, Liam S Turk, et al.
Bioorganic & Medicinal Chemistry Letters|June 18, 2011
Design, synthesis and evaluation of monovalent Smac mimetics that bind to the BIR2 domain of the anti-apoptotic protein XIAPMarcos González-López, Kate Welsh, Darren Finlay, et al.
ACS Chemical Biology|January 18, 2013
Expedient synthesis of highly potent antagonists of inhibitor of apoptosis proteins (IAPs) with unique selectivity for ML-IAPMitchell Vamos, Kate Welsh, Darren Finlay, et al.
Journal of the American College of Cardiology|August 20, 2013
Clinical manifestations of fibromuscular dysplasia vary by patient sex: a report of the United States registry for fibromuscular dysplasiaEsther S H Kim, Jeffrey W Olin, James B Froehlich, et al.
The Journal of Biological Chemistry|October 10, 2009
TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (tnf) to efficiently activate nf-{kappa}b and to prevent tnf-induced apoptosisJames E Vince, Delara Pantaki, Rebecca Feltham, et al.
The Biochemical Journal|November 19, 2024
On the function of TRAP substrate-binding proteins: the isethionate-specific binding protein IsePMichael C Newton-Vesty, Michael J Currie, James S Davies, et al.
Structure (London, England : 1993)|November 6, 2025
Structural basis of isethionate transport by a TRAP transporter from a sulfate-reducing bacteriumMichael C Newton-Vesty, Mariafrancesca Scalise, Sam A Jamieson, et al.
Pageof 11